A certain segment of those who recover from COVID-19 experience lingering symptoms such as breathing difficulty, fatigue, post-exertional malaise, brain fog, and headache. In order to better understand these post-COVID symptoms, the United…

On September 16, the American Dental Hygienists’ Association (ADHA) released a new update to its “Interim Guidance on Returning to Work,” which was initially published in May 2020. The update is based on revisions to the United States…

FluoroDose Fluoride Varnish with Xylitol just got an upgrade to have top-of-the-line packaging to match its top-of-the-line quality! The award-winning varnish is now packaged in our new enclosed LolliTray, a fully enclosed package designed…

Tennessee has earned the unwanted prize of being home to the most new COVID-19 cases per capita in the United States. One out of 81 Tennessee residents tested positive for SARS-CoV-2 during the past week. The number of COVID-19 cases in the…

All oral health professionals, exhibitors, guests, and staff members who wish to attend the annual meeting, SmileCon, of the American Dental Association (ADA) must provide proof of COVID-19 vaccination or a negative test result. The meeting…

While booster shots to the COVID-19 vaccination are recommended for those who are immunocompromised, whether healthy, previously vaccinated individuals need a booster remains an unanswered question. A group of public health experts recently…

On September 10, the United States Centers for Disease Control and Prevention (CDC) announced an update to the agency’s COVID-19 infection prevention and control guidance for healthcare settings. The update is designed to provide a…

While many variants of SARS-CoV-2 exist, only four have raised alarm. The World Health Organization designates those variants that pose the greatest health threats as “variants of concern.” Thus far, the Alpha, Beta, Gamma, Delta, and Mu…

The American Dental Association (ADA) Science and Research Institute, together with other U.S. and international collaborators, has been awarded a three-year, $3.5 million grant.

The United States Food and Drug Administration (FDA) will review 2 months of safety data from clinical trials on the safety and efficacy of COVID-19 vaccines among children ages 5 to 11. This suggests that COVID-19 vaccine manufacturers…